Detalles de la búsqueda
1.
Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts.
Front Immunol
; 9: 1614, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30061887
Resultados
1 -
1
de 1
1
Próxima >
>>